[Therapeutic intensification: contribution of G-CSF].
Marty
M
M
Service d'Oncologie Médicale, Hôpital Saint-Louis, Paris, France.
Extra
J M
JM
Giacchetti
S
S
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000601:surgery; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor